Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-10-017129)

Filing Details

Accession Number:: 0001225208-10-017129
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-07-13 13:00:00
Reporting Period:: 2010-07-12

Filing Date:: 2010-07-13
Accepted Time:: 2010-07-13 14:34:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
901219	Human Genome Sciences Inc	HGSI	In Vitro & In Vivo Diagnostic Substances (2835)	223178468

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1307935	Thomas Watkins	14200 Shady Grove Road Rockville MD 20850	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-07-12	801	$19.64	166,075	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,000	Indirect	By Children

Footnotes

Acquired under the issuer's Employee Stock Purchase Plan in a transaction exempt from Section 16(b) under Rule 16b-3.